Artificial intelligence can help healthcare teams spend less time organising information and more time using it well. Potential applications include drafting consultation notes, finding missing information and preparing clearer follow-up instructions. Improving care requires more than a fluent answer: the information must be accurate, useful for the patient and checked by the people responsible for the clinical decision.
This guide looks at three questions for Singapore healthcare and technology teams: where could AI improve efficiency, how might it support quality, and what would make its use safer? The examples below describe possible workflows. They do not imply that every feature is available at Digital Health Clinic or that any particular AI product has demonstrated better clinical outcomes.
Efficiency: reduce work around the consultation
A practical starting point is a specific task that staff can describe and measure. An AI scribe, for example, can draft a note from a clinical conversation for a clinician to check. Other proposed uses include organising referral documents, extracting dates from reports, or preparing a draft patient summary from an agreed care plan. Each requires a clear source of truth and a review step.
There is encouraging evidence, with important limits. A 2026 Singapore observational study followed nine experienced clinicians across 169 specialist outpatient consultations. AI-scribe use was associated with documentation time falling from a mean of 5.3 to 4.5 minutes per consultation, alongside more eye contact. Consultation duration and total time per patient did not change significantly. The small, non-randomised study cannot establish that every clinic would see the same results.
A randomised trial involving 238 outpatient physicians also found that results differed between two scribe products: one reduced time spent writing notes compared with usual care; the other did not show a significant reduction. These findings support testing the actual tool in the actual workflow. Faster drafting does not necessarily mean shorter visits, lower costs or safer care.
Quality: make information easier to check and act on
Chronic disease follow-up often involves several sources of information: previous consultations, medicines, laboratory reports and home measurements. A useful AI assistant could assemble a draft timeline, highlight missing dates and point the clinician to the source behind each item. Quality depends on whether that makes the final clinical record and care plan more accurate and complete.
Consider an illustrative workflow for a person attending a diabetes and blood-pressure review. The system groups dated results, identifies an unclear medicine entry and marks an older measurement as historical. The clinician then checks the original records, asks the patient what they are currently taking and decides which information is relevant. An unknown value stays unknown; it is not filled in with a plausible guess.
After the clinician agrees a plan with the patient, AI could help draft a plain-language summary. The clinician checks that the actions, timing and follow-up match the actual discussion. This example illustrates a design approach, not a tested DigitalHealth product outcome. A polished summary is useful only when it faithfully represents the agreed plan.
Safety: design for errors as well as useful answers
The World Health Organization’s guidance on generative AI identifies risks including false or incomplete statements, biased outputs, cybersecurity threats and automation bias: people may overlook an error because a system presents an answer confidently. These risks matter when a draft influences a medical record or a care decision.
Useful safeguards include keeping outputs visibly marked as drafts, showing where information came from, testing for omitted facts and making it straightforward to reject an answer. A human review step needs enough time and access to the original information to be meaningful. For higher-risk decisions, a signature alone is not evidence that the reviewer checked the reasoning.
AI should not independently diagnose a patient, change treatment or send unverified clinical instructions in the workflows described here. Teams need a defined route for uncertain results, system failures and clinical escalation. An AI tool cannot supply an examination or a missing test, and a teleconsultation remains unsuitable when the patient needs in-person or emergency assessment.
Singapore’s framework: shared responsibilities and protected data
Singapore’s AI in Healthcare Guidelines, version 2.0, clarify responsibilities for developers, healthcare organisations deploying AI, and healthcare professionals using it. MOH describes AI as supporting healthcare professionals, with attention to transparency, risk assessment and safe deployment. The guidance complements HSA’s software-as-medical-device regulatory guidelines.
For a clinic evaluating a tool, practical questions include its intended purpose, the population on which it was evaluated, its known failure modes and who manages incidents after launch. A model update can change behaviour, so evaluation needs to continue after initial adoption.
Patient information also needs protection throughout the process. MOH states that data-security requirements apply to AI tools processing patient data, whether they run in third-party clouds or on premises. Teams should establish approved access, retention and vendor arrangements before using identifiable records. Staff should not paste such records into an unapproved consumer AI service.
Measure efficiency, quality and safety together
The following is a proposed evaluation scorecard for a clinic pilot. Define the task and baseline first, then agree what would justify continuing, changing or stopping the pilot. Include the time spent checking and correcting outputs.
| Aim | What to measure | Question to answer |
|---|
| Efficiency | Drafting, review and correction time; unfinished notes | Does the whole task take less staff time? |
| Quality | Important omissions, incorrect facts and agreement with source records | Is the final information more reliable? |
| Safety | Clinically significant errors, near misses and escalation failures | What harm could still occur? |
| Fairness | Performance across relevant languages, ages and clinical situations | Who benefits less or faces more errors? |
| Patient experience | Understanding of the care plan and comfort with AI use | Does the patient experience improve? |
A time-saving result does not by itself demonstrate better disease control or fewer hospital admissions. Claims about those outcomes need appropriate clinical evaluation. Teams should record which tool version was tested and repeat relevant checks when the system or its use changes.
Digital Health Clinic’s AI development direction
Digital Health Clinic offers GP teleconsultations for suitable common acute conditions and ongoing chronic conditions in Singapore, subject to clinical assessment. Digital Health is also developing AI solutions intended to support clinicians and improve the efficiency and quality of chronic disease management.
Our Remedy A.I. development overview describes areas such as organising clinical information, working with local guidance and making supporting evidence easier to inspect. These are development aims, not a claim that improved patient outcomes have already been proven. Our separate article about the Vietnam validation project provides project-specific background; this guide focuses on how healthcare teams can evaluate AI more broadly.
Why this matters to the technology community
Healthcare AI requires clinicians and technology professionals to solve problems together. Software teams shape how sources, uncertainty and errors appear on screen. Healthcare teams define what information matters and which decisions require clinical judgement. Patients help identify whether the resulting service is understandable and usable.
For background on the digital infrastructure around remote care, the Singapore Computer Society’s telemedicine overview discusses enabling technologies, patient dashboards and electronic records. The next useful conversation is how those systems can support carefully evaluated AI. SCS is linked here as a technology resource; this article does not imply an SCS partnership or endorsement.
Common questions about AI in healthcare
Can AI improve healthcare efficiency?
It can assist with specific tasks such as drafting notes and organising information. The benefit depends on the tool, setting and time needed to check its output. Measure the complete workflow rather than draft speed alone.
Does using AI automatically make care safer?
No. AI can introduce errors as well as help identify information that needs attention. Appropriate evaluation, protected data, clear responsibilities and meaningful clinical review are needed.
How could AI help with chronic disease management?
Potential uses include organising dated results, identifying missing information and drafting summaries for clinicians to verify. Clinical decisions need to reflect the patient’s current situation, preferences and assessment.
Has Digital Health’s AI been shown here to improve patient outcomes?
No. This article describes development aims and general evaluation principles. The external scribe studies concern other systems and should not be read as evidence of Remedy A.I.’s performance.
Sources and editorial note
Sources checked on 8 November 2026: Tan and colleagues, JMIR Medical Informatics (2026); Lukac and colleagues, NEJM AI (2025); WHO guidance; MOH AIHGle 2.0; and MOH on patient-data security. Written by the DigitalHealth.sg editorial team. This technology explainer provides general information, not individual medical advice or an independent evaluation of a commercial product.
